Analysts reconfirmed revenue and earnings forecasts for Edwa...
Analysts reconfirmed revenue and earnings forecasts for Edwards Lifesciences, indicating no major change in business expectations following recent results. The price target increase suggests analysts believe the business's intrinsic value is improving.
US$90.47 - That's What Analysts Think Edwards Lifesciences Corporation (NYSE:EW) Is Worth After These Results
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment